Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Hydroxychloroquine in mild-to-moderate COVID-19: a placebo-controlled double blind trial

Dubee et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2021.03.005 (date from preprint), HYCOVID, NCT04325893
Oct 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Death at day 28 46% Improvement Relative Risk Combined intubation/de.. 26% HCQ  HYCOVID  LATE TREATMENT  RCT Is late treatment with HCQ beneficial for COVID-19? RCT 247 patients in France (April - May 2020) Lower mortality (p=0.21) and death/intubation (p=0.48), not sig. c19hcq.org Dubee et al., Clinical Microbiology an.., Oct 2020 FavorsHCQ Favorscontrol 0 0.5 1 1.5 2+
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020, now with p < 0.00000000001 from 419 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 109 treatments. c19hcq.org
Small early terminated late stage (60% on oxygen) RCT in France showing 46% lower mortality.
mortality at 28 days relative risk RR 0.54 [0.21-1.42]
combined mortality/intubation at 28 days relative risk RR 0.74 [0.33-1.70]
If not stopped early and the same trend continued, statistical significance would be reached on 28 day mortality after ~550 patients (1,300 patients were planned).
Mortality results are not provided for subgroups. For the subgroups receiving AZ:
No safety concerns were identified. This study has been presented as negative, however the results do not support that conclusion.
risk of death at day 28, 46.0% lower, RR 0.54, p = 0.21, treatment 6 of 124 (4.8%), control 11 of 123 (8.9%), NNT 24.
risk of combined intubation/death at day 28, 26.0% lower, RR 0.74, p = 0.48, treatment 9 of 124 (7.3%), control 12 of 123 (9.8%), NNT 40.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Dubee et al., 21 Oct 2020, Randomized Controlled Trial, France, peer-reviewed, median age 77.0, 18 authors, study period 2 April, 2020 - 21 May, 2020, average treatment delay 5.0 days, trial NCT04325893 (history) (HYCOVID).
This PaperHCQAll
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
Vincent Dubée, Pierre-Marie Roy, Bruno Vielle, Elsa Parot-Schinkel, Odile Blanchet, Astrid Darsonval, Caroline Lefeuvre, Chadi Abbara, Sophie Boucher, Edouard Devaud, Olivier Robineau, Patrick Rispal, Thomas Guimard, Emma D’anglejean, Sylvain Diamantis, Marc-Antoine Custaud, Isabelle Pellier, Alain Mercat, Antoine Brangier, Philippe Codron, Jean Michel Lemée, Virginie Pichon, Robin Dhersin, Geoffrey Urbanski, Christian Lavigne, Roxane Courtois, Hélène Danielou, Jonathan Lebreton, Rémi Vatan, Nicolas Crochette, Jean-Baptiste Lainé, Lucia Perez, Sophie Blanchi, Hikombo Hitoto, Louis Bernard, François Maillot, Sylvain Marchand Adam, Jean-Philippe Talarmin, Emeline Gaigneux, Pauline Motte-Vincent, Marine Morrier, Dominique Merrien, Yves Bleher, Maxime Flori, Amélie Ducet-Boiffard, Orane Colin, Ronan Février, Pauline Thill, Macha Tetart, François Demaeght, Barthelemy Lafond-Desmurs, Maxime Pradier, Agnes Meybeck, Marjorie Picaud, Thierry Prazuck, Guillaume Chapelet, Agnès Rouaud, Paul Le Turnier, Simon Sunder, Aurélien Lorleac'h, Christophe Dollon, Antoine Jacquet, Francois Le Vely, Pierre Gazeau, Séverine Ansart, Hélène Roger, François Laterza, Rodolphe Buzelé, Fella Tahmi, Raphael Lepeule, Karine Lacombe, Bénédicte Lefebvre, Thomas Célarier, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers, Marc Bernard, Camille Garnier, Morgane Mourguet, Gregory Pugnet, Sara Vienne-Noyes, Guillaume Martin-Blondel, Pierre Delobel, Gaspard Grouteau, Alexa Debard, Laurent Guilleminault, Pauline Arias, Catherine Chakvetadze, Clara Flateau, Aude Kopp, Alain Putot, Jeremy Barben, Suzanne Mouries Martin, Valentine Nuss, Lionel Piroth, Yann-Erick Claessens, Veronique Hentgen, Martin Martinot, Maxime Bach-Bunner, Thomas Bonijoly, Simon Gravier, Jean-Marc Michel, Mathilde Andreu, Mélanie Roriz, Aurélie Baldolli, Julia Brochard, Olivier Grossi, Samuel Pineau, Josselin Brisset, Edouard Desvaux, Guillaume Gondran, Jean-François Faucher, Paul-Antoine Quesnel, Holy Bezanahary, Clément Danthu, Blandine Gutierrez, Kim Ly, Yannick Simonneau, Anne Cypierre, Pauline Pinet, Hélène Durox, Sophie Ducroix-Roubertou, Claire Genet, Guillaume Beraud, Gwenael Le Moal, Blandine Rammaert, Jean-Philippe Lanoix, Claire Andrejak, Cédric Joseph, Sandrine Soriot-Thomas, Robin Dhote, Sébastien Abad, Ruben Benainous, Jean-François Boitiaux, Guillaume Briend, Celine Gonfroy, Stanislas Harent, Aurore Lagrange, Alina Tone, Laura Wayenberg, Sophie Desoutter, Nicolas Ettahar, Thomas Gey, Vincent Leroy, Sacha Gaillard, Andrea Toma, Amaury Broussier, Sandrine Etienne, Yann Spivac, Benoit Martha, Nathalie Roch, Pierre Diaz, Danièle N’guyen Baranoff, Stanislas Rebaudet, François Jourda, Valérie Zeller, Boris Bienvenu, Arnaud Boyer, Isabelle Pellier, Alain Mercat, Astrid Darsonval, Odile Blanchet, Marc-Antoine Custaud, Caroline Lefeuvre, Elsa Parot-Schinkel, Bruno Vielle, Marie Briet, Pierre-Marie Roy, Vincent Dubée, Bertrand Guidet, Patrick Mismetti, Eric Vicaut, Olivier Sanchez, Philippe Girard, Antoine Elias, Francis Couturaud, Béatrice Gable, Sybille Lazareff, Loïc Carballido, Catherine Hue, Jean-Marie Chrétien, Adrien Goraguer, Lucie Van Eeckhoutte
Clinical Microbiology and Infection, doi:10.1016/j.cmi.2021.03.005
Objectives: To determine whether hydroxychloroquine decreases the risk of adverse outcome in patients with mild to moderate coronavirus disease 2019 (COVID-19) at high risk of worsening. Methods: We conducted a multicentre randomized double-blind placebo-controlled trial evaluating hydroxychloroquine in COVID-19 patients with at least one of the following risk factors for worsening: need for supplemental oxygen, age 75 years, age between 60 and 74 years and presence of at least one co-morbidity. Severely ill patients requiring oxygen therapy >3 L/min or intensive care were excluded. Eligible patients were randomized in a 1:1 ratio to receive either 800 mg hydroxychloroquine on day 0 followed by 400 mg per day for 8 days or a placebo. The primary end point was a composite of death or start of invasive mechanical ventilation within 14 days following randomization. Secondary end points included mortality and clinical evolution at days 14 and 28, and viral shedding at days 5 and 10. Results: The trial was stopped after 250 patients were included because of a slowing down of the pandemic in France. The intention-to-treat population comprised 123 and 124 patients in the placebo and hydroxychloroquine groups, respectively. The median age was 77 years (interquartile range 58 e86 years) and 151/250 (60.4%) patients required oxygen therapy. The primary end point occurred in 9/ 124 (7.3%) patients in the hydroxychloroquine group and 8/123 (6.5%) patients in the placebo group
Authors' contributions VD, PMR, HP, EPS and AM conceptualized the study and its methodology, VD and PMR supervised the conduct of the study and wrote the original draft of the manuscript. BV was in charge of data curation and formal analysis. SB, ED, OR, PR, TG, EA, SD and MAC participated in data collection. AD was responsible for preparation and shipping of study drugs. CL and OB were in charge of biological samples. CA was responsible for drug safety. All authors reviewed and edited the manuscript and approved its final version. All authors contributed significantly to the study and agree to be accountable for all aspects of the work. VD, PMR, IP and AM take responsibility for the publication. Access to data Anonymized individual data are available upon reasonable request to DataManagement.DRCI@chu-angers.fr. Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi.org/10.1016/j.cmi.2021.03.005.
References
Cao, Wang, Wen, Liu, Wang et al., A trial of lopinavireritonavir in adults hospitalized with severe Covid-19, N Engl J Med
Cavalcanti, Zampieri, Rosa, Azevedo, Veiga et al., Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19, N Engl J Med
Chen, Li, Song, Hu, Su et al., Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China, JAMA Netw Open
Chen, Liu, Liu, Liu, Xu et al., A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19, doi:10.3785/j.issn.1008-9292.2020.03.03
Fiolet, Guihur, Rebeaud, Mulot, Peiffer-Smadja et al., Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis, Clin Microbiol Infect
G Erard, Romani, Fresse, Viard, Parassol et al., Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers, Therapie
Gautret, Lagier, Parola, Hoang, Meddeb et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial, Int J Antimicrobiol Agents
Geleris, Sun, Platt, Zucker, Baldwin et al., Observational study of hydroxychloroquine in hospitalized patients with Covid-19, N Engl J Med
He, Lau, Wu, Deng, Wang et al., Temporal dynamics in viral shedding and transmissibility of COVID-19, Nat Med
Mah Evas, Tran, Roumier, Chabrol, Paule et al., Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data, BMJ
Mallat, Hamed, Balkis, Mohamed, Mooty et al., Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease, Medicine
Mehra, Desai, Ruschitzka, Patel, RETRACTED: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet
Mitj A, Corbacho-Monn E, Ubals, Tebe, Peñafiel et al., Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial, Clin Infect Dis
Recovery Collaborative Group, Horby, Lim, Emberson, Mafham et al., Dexamethasone in hospitalized patients with Covid-19 e preliminary report, N Engl J Med
Recovery Collaborative, Effect of hydroxychloroquine in hospitalized patients with Covid-19, N Engl J Med, doi:10.1056/NEJMoa2022926
Rosenberg, Dufort, Udo, Wilberschied, Kumar et al., Association of treatment with hydroxychloroquine or azithromycin with inhospital mortality in patients with COVID-19 in New York State, JAMA
Self, Semler, Leither, Casey, Angus et al., Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial, JAMA
Skipper, Pastick, Engen, Bangdiwala, Abassi et al., Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial, Ann Intern Med
Tang, Cao, Han, Wang, Chen et al., Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial, BMJ
Team, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) d China, CCDCW
Wang, Cao, Zhang, Yang, Liu et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res
Widders, Broom, Broom, SARS-CoV-2: the viral shedding vs infectivity dilemma, Infect Dis Health
Zheng, Yu, Feng, Lou, Zou, Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, JanuaryeMarch 2020: retrospective cohort study, BMJ
{ 'indexed': {'date-parts': [[2024, 3, 1]], 'date-time': '2024-03-01T06:29:42Z', 'timestamp': 1709274582110}, 'reference-count': 24, 'publisher': 'Elsevier BV', 'issue': '8', 'license': [ { 'start': { 'date-parts': [[2021, 8, 1]], 'date-time': '2021-08-01T00:00:00Z', 'timestamp': 1627776000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 4, 2]], 'date-time': '2021-04-02T00:00:00Z', 'timestamp': 1617321600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'funder': [ { 'DOI': '10.13039/501100005978', 'name': 'Ministere de la Sante et des Solidarites', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/501100007745', 'name': 'Angers Loire Metropole', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/501100013414', 'name': 'Regional Council of Pays de la Loire', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/501100004571', 'name': 'Ministère des Affaires Sociales et de la Santé', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': ['clinicalmicrobiologyandinfection.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 8]]}, 'DOI': '10.1016/j.cmi.2021.03.005', 'type': 'journal-article', 'created': {'date-parts': [[2021, 4, 2]], 'date-time': '2021-04-02T02:08:00Z', 'timestamp': 1617329280000}, 'page': '1124-1130', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 28, 'title': 'Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double ' 'blind trial', 'prefix': '10.1016', 'volume': '27', 'author': [ {'given': 'Vincent', 'family': 'Dubée', 'sequence': 'first', 'affiliation': []}, {'given': 'Pierre-Marie', 'family': 'Roy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bruno', 'family': 'Vielle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elsa', 'family': 'Parot-Schinkel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Odile', 'family': 'Blanchet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Astrid', 'family': 'Darsonval', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caroline', 'family': 'Lefeuvre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chadi', 'family': 'Abbara', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Boucher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Edouard', 'family': 'Devaud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olivier', 'family': 'Robineau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Rispal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Guimard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emma', 'family': 'd’Anglejean', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sylvain', 'family': 'Diamantis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc-Antoine', 'family': 'Custaud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isabelle', 'family': 'Pellier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alain', 'family': 'Mercat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antoine', 'family': 'Brangier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Codron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean Michel', 'family': 'Lemée', 'sequence': 'additional', 'affiliation': []}, {'given': 'Virginie', 'family': 'Pichon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robin', 'family': 'Dhersin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Geoffrey', 'family': 'Urbanski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian', 'family': 'Lavigne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roxane', 'family': 'Courtois', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hélène', 'family': 'Danielou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Lebreton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rémi', 'family': 'Vatan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicolas', 'family': 'Crochette', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Baptiste', 'family': 'Lainé', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lucia', 'family': 'Perez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Blanchi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hikombo', 'family': 'Hitoto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Louis', 'family': 'Bernard', 'sequence': 'additional', 'affiliation': []}, {'given': 'François', 'family': 'Maillot', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sylvain', 'family': 'Marchand Adam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Philippe', 'family': 'Talarmin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emeline', 'family': 'Gaigneux', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pauline', 'family': 'Motte-Vincent', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marine', 'family': 'Morrier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dominique', 'family': 'Merrien', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yves', 'family': 'Bleher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maxime', 'family': 'Flori', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amélie', 'family': 'Ducet-Boiffard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Orane', 'family': 'Colin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ronan', 'family': 'Février', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pauline', 'family': 'Thill', 'sequence': 'additional', 'affiliation': []}, {'given': 'Macha', 'family': 'Tetart', 'sequence': 'additional', 'affiliation': []}, {'given': 'François', 'family': 'Demaeght', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Barthelemy', 'family': 'Lafond-Desmurs', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maxime', 'family': 'Pradier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Agnes', 'family': 'Meybeck', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marjorie', 'family': 'Picaud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thierry', 'family': 'Prazuck', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillaume', 'family': 'Chapelet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Agnès', 'family': 'Rouaud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Le Turnier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Sunder', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aurélien', 'family': "Lorleac'h", 'sequence': 'additional', 'affiliation': []}, {'given': 'Christophe', 'family': 'Dollon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antoine', 'family': 'Jacquet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francois', 'family': 'Le Vely', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre', 'family': 'Gazeau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Séverine', 'family': 'Ansart', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hélène', 'family': 'Roger', 'sequence': 'additional', 'affiliation': []}, {'given': 'François', 'family': 'Laterza', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rodolphe', 'family': 'Buzelé', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fella', 'family': 'Tahmi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raphael', 'family': 'Lepeule', 'sequence': 'additional', 'affiliation': []}, {'given': 'Karine', 'family': 'Lacombe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bénédicte', 'family': 'Lefebvre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Célarier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amandine', 'family': 'Gagneux-Brunon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elisabeth', 'family': 'Botelho-Nevers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc', 'family': 'Bernard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Camille', 'family': 'Garnier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Morgane', 'family': 'Mourguet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gregory', 'family': 'Pugnet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sara', 'family': 'Vienne-Noyes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillaume', 'family': 'Martin-Blondel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre', 'family': 'Delobel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gaspard', 'family': 'Grouteau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexa', 'family': 'Debard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laurent', 'family': 'Guilleminault', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pauline', 'family': 'Arias', 'sequence': 'additional', 'affiliation': []}, {'given': 'Catherine', 'family': 'Chakvetadze', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clara', 'family': 'Flateau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aude', 'family': 'Kopp', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alain', 'family': 'Putot', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jeremy', 'family': 'Barben', 'sequence': 'additional', 'affiliation': []}, {'given': 'Suzanne', 'family': 'Mouries Martin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Valentine', 'family': 'Nuss', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lionel', 'family': 'Piroth', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yann-Erick', 'family': 'Claessens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Veronique', 'family': 'Hentgen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Martinot', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maxime', 'family': 'Bach-Bunner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Bonijoly', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Gravier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Marc', 'family': 'Michel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mathilde', 'family': 'Andreu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mélanie', 'family': 'Roriz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aurélie', 'family': 'Baldolli', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julia', 'family': 'Brochard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olivier', 'family': 'Grossi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samuel', 'family': 'Pineau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Josselin', 'family': 'Brisset', 'sequence': 'additional', 'affiliation': []}, {'given': 'Edouard', 'family': 'Desvaux', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillaume', 'family': 'Gondran', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-François', 'family': 'Faucher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul-Antoine', 'family': 'Quesnel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Holy', 'family': 'Bezanahary', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clément', 'family': 'Danthu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Blandine', 'family': 'Gutierrez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kim', 'family': 'Ly', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yannick', 'family': 'Simonneau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anne', 'family': 'Cypierre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pauline', 'family': 'Pinet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hélène', 'family': 'Durox', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Ducroix-Roubertou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Genet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillaume', 'family': 'Beraud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gwenael', 'family': 'Le Moal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Blandine', 'family': 'Rammaert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Philippe', 'family': 'Lanoix', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Andrejak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cédric', 'family': 'Joseph', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sandrine', 'family': 'Soriot-Thomas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robin', 'family': 'Dhote', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sébastien', 'family': 'Abad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ruben', 'family': 'Benainous', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-François', 'family': 'Boitiaux', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillaume', 'family': 'Briend', 'sequence': 'additional', 'affiliation': []}, {'given': 'Celine', 'family': 'Gonfroy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stanislas', 'family': 'Harent', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aurore', 'family': 'Lagrange', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alina', 'family': 'Tone', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Wayenberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Desoutter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicolas', 'family': 'Ettahar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Gey', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vincent', 'family': 'Leroy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sacha', 'family': 'Gaillard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Toma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amaury', 'family': 'Broussier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sandrine', 'family': 'Etienne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yann', 'family': 'Spivac', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benoit', 'family': 'Martha', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathalie', 'family': 'Roch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre', 'family': 'Diaz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Danièle', 'family': 'N’guyen Baranoff', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stanislas', 'family': 'Rebaudet', 'sequence': 'additional', 'affiliation': []}, {'given': 'François', 'family': 'Jourda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Valérie', 'family': 'Zeller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Boris', 'family': 'Bienvenu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arnaud', 'family': 'Boyer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isabelle', 'family': 'Pellier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alain', 'family': 'Mercat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Astrid', 'family': 'Darsonval', 'sequence': 'additional', 'affiliation': []}, {'given': 'Odile', 'family': 'Blanchet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc-Antoine', 'family': 'Custaud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caroline', 'family': 'Lefeuvre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elsa', 'family': 'Parot-Schinkel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bruno', 'family': 'Vielle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marie', 'family': 'Briet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre-Marie', 'family': 'Roy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vincent', 'family': 'Dubée', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bertrand', 'family': 'Guidet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Mismetti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eric', 'family': 'Vicaut', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olivier', 'family': 'Sanchez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Girard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antoine', 'family': 'Elias', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francis', 'family': 'Couturaud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Béatrice', 'family': 'Gable', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sybille', 'family': 'Lazareff', 'sequence': 'additional', 'affiliation': []}, {'given': 'Loïc', 'family': 'Carballido', 'sequence': 'additional', 'affiliation': []}, {'given': 'Catherine', 'family': 'Hue', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Marie', 'family': 'Chrétien', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adrien', 'family': 'Goraguer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lucie van', 'family': 'Eeckhoutte', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.cmi.2021.03.005_bib1', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in\xa0vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.cmi.2021.03.005_bib2', 'doi-asserted-by': 'crossref', 'first-page': '105949', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'volume': '56', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrobiol Agents'}, { 'key': '10.1016/j.cmi.2021.03.005_bib3', 'doi-asserted-by': 'crossref', 'DOI': '10.1056/NEJMoa2019014', 'article-title': 'Hydroxychloroquine with or without azithromycin in mild-to-moderate ' 'Covid-19', 'author': 'Cavalcanti', 'year': '2020', 'journal-title': 'N\xa0Engl J Med'}, { 'key': '10.1016/j.cmi.2021.03.005_bib4', 'first-page': 'M20', 'article-title': 'Hydroxychloroquine in nonhospitalized adults with early COVID-19: a ' 'randomized trial', 'author': 'Skipper', 'year': '2020', 'journal-title': 'Ann Intern Med'}, { 'key': '10.1016/j.cmi.2021.03.005_bib5', 'doi-asserted-by': 'crossref', 'first-page': 'm1844', 'DOI': '10.1136/bmj.m1844', 'article-title': 'Clinical efficacy of hydroxychloroquine in patients with covid-19 ' 'pneumonia who require oxygen: observational comparative study using ' 'routine care data', 'volume': '369', 'author': 'Mahévas', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.cmi.2021.03.005_bib6', 'doi-asserted-by': 'crossref', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of treatment with hydroxychloroquine or azithromycin with ' 'in-hospital mortality in patients with COVID-19 in New York State', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.cmi.2021.03.005_bib7', 'doi-asserted-by': 'crossref', 'first-page': 'm1849', 'DOI': '10.1136/bmj.m1849', 'article-title': 'Hydroxychloroquine in patients with mainly mild to moderate coronavirus ' 'disease 2019: open label, randomised controlled trial', 'volume': '369', 'author': 'Tang', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.cmi.2021.03.005_bib8', 'first-page': 'ciaa1009', 'article-title': 'Hydroxychloroquine for early treatment of adults with mild Covid-19: a ' 'randomized-controlled trial', 'author': 'Mitjà', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.cmi.2021.03.005_bib9', 'doi-asserted-by': 'crossref', 'first-page': '2411', 'DOI': '10.1056/NEJMoa2012410', 'article-title': 'Observational study of hydroxychloroquine in hospitalized patients with ' 'Covid-19', 'volume': '382', 'author': 'Geleris', 'year': '2020', 'journal-title': 'N\xa0Engl J Med'}, { 'issue': '1', 'key': '10.1016/j.cmi.2021.03.005_bib10', 'doi-asserted-by': 'crossref', 'first-page': '19', 'DOI': '10.1016/j.cmi.2020.08.022', 'article-title': 'Effect of hydroxychloroquine with or without azithromycin on the ' 'mortality of COVID-19 patients: a systematic review and meta-analysis', 'volume': '27', 'author': 'Fiolet', 'year': '2021', 'journal-title': 'Clin Microbiol Infect'}, { 'key': '10.1016/j.cmi.2021.03.005_bib11', 'unstructured': 'RECOVERY Collaborative Group. Effect of hydroxychloroquine in ' 'hospitalized patients with Covid-19. N Engl J Med. ' 'https://www.nejm.org/doi/full/10.1056/NEJMoa2022926.'}, { 'key': '10.1016/j.cmi.2021.03.005_bib12', 'series-title': 'COVID-19 treatment trial design - master protocol', 'year': '2020'}, { 'key': '10.1016/j.cmi.2021.03.005_bib13', 'first-page': '113', 'article-title': 'The epidemiological characteristics of an outbreak of 2019 novel ' 'coronavirus diseases (COVID-19) — China, 2020', 'volume': '2', 'year': '2020', 'journal-title': 'CCDCW'}, { 'key': '10.1016/j.cmi.2021.03.005_bib14', 'doi-asserted-by': 'crossref', 'first-page': '1787', 'DOI': '10.1056/NEJMoa2001282', 'article-title': 'A\xa0trial of lopinavir–ritonavir in adults hospitalized with severe ' 'Covid-19', 'volume': '382', 'author': 'Cao', 'year': '2020', 'journal-title': 'N\xa0Engl J Med'}, { 'key': '10.1016/j.cmi.2021.03.005_bib15', 'doi-asserted-by': 'crossref', 'first-page': '371', 'DOI': '10.1016/j.therap.2020.05.002', 'article-title': '"Off-label" use of hydroxychloroquine, azithromycin, ' 'lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac ' 'adverse drug reactions by the French Network of Pharmacovigilance ' 'Centers', 'volume': '75', 'author': 'Gérard', 'year': '2020', 'journal-title': 'Therapie'}, { 'key': '10.1016/j.cmi.2021.03.005_bib16', 'first-page': '31180', 'article-title': 'RETRACTED: hydroxychloroquine or chloroquine with or without a ' 'macrolide for treatment of COVID-19: a multinational registry analysis', 'volume': 'S0140–6736', 'author': 'Mehra', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.cmi.2021.03.005_bib17', 'doi-asserted-by': 'crossref', 'first-page': '2165', 'DOI': '10.1001/jama.2020.22240', 'article-title': 'Effect of hydroxychloroquine on clinical status at 14 days in ' 'hospitalized patients with COVID-19: a randomized clinical trial', 'volume': '324', 'author': 'Self', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.cmi.2021.03.005_bib18', 'doi-asserted-by': 'crossref', 'DOI': '10.1097/MD.0000000000023720', 'article-title': 'Hydroxychloroquine is associated with slower viral clearance in ' 'clinical COVID-19 patients with mild to moderate disease', 'volume': '99', 'author': 'Mallat', 'year': '2020', 'journal-title': 'Medicine (Baltimore)'}, {'key': '10.1016/j.cmi.2021.03.005_bib19', 'author': 'Chen'}, { 'key': '10.1016/j.cmi.2021.03.005_bib20', 'doi-asserted-by': 'crossref', 'first-page': '672', 'DOI': '10.1038/s41591-020-0869-5', 'article-title': 'Temporal dynamics in viral shedding and transmissibility of COVID-19', 'volume': '26', 'author': 'He', 'year': '2020', 'journal-title': 'Nat Med'}, { 'key': '10.1016/j.cmi.2021.03.005_bib21', 'doi-asserted-by': 'crossref', 'first-page': '210', 'DOI': '10.1016/j.idh.2020.05.002', 'article-title': 'SARS-CoV-2: the viral shedding vs infectivity dilemma', 'volume': '25', 'author': 'Widders', 'year': '2020', 'journal-title': 'Infect Dis Health'}, { 'key': '10.1016/j.cmi.2021.03.005_bib22', 'doi-asserted-by': 'crossref', 'first-page': 'm1443', 'DOI': '10.1136/bmj.m1443', 'article-title': 'Viral load dynamics and disease severity in patients infected with ' 'SARS-CoV-2 in Zhejiang province, China, January–March 2020: ' 'retrospective cohort study', 'volume': '369', 'author': 'Zheng', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.cmi.2021.03.005_bib23', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2020.11122', 'article-title': 'Assessment of hypokalemia and clinical characteristics in patients with ' 'coronavirus disease 2019 in Wenzhou, China', 'volume': '3', 'author': 'Chen', 'year': '2020', 'journal-title': 'JAMA Netw Open'}, { 'key': '10.1016/j.cmi.2021.03.005_bib24', 'article-title': 'Dexamethasone in hospitalized patients with Covid-19 – preliminary ' 'report', 'author': 'Horby', 'year': '2020', 'journal-title': 'N\xa0Engl J Med'}], 'container-title': 'Clinical Microbiology and Infection', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1198743X21001403?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1198743X21001403?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 8, 17]], 'date-time': '2023-08-17T00:32:23Z', 'timestamp': 1692232343000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1198743X21001403'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 8]]}, 'references-count': 24, 'journal-issue': {'issue': '8', 'published-print': {'date-parts': [[2021, 8]]}}, 'alternative-id': ['S1198743X21001403'], 'URL': 'http://dx.doi.org/10.1016/j.cmi.2021.03.005', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.1101/2020.10.19.20214940', 'asserted-by': 'object'}]}, 'ISSN': ['1198-743X'], 'subject': ['Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'Clinical Microbiology and Infection', 'published': {'date-parts': [[2021, 8]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a ' 'placebo-controlled double blind trial', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Clinical Microbiology and Infection', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.cmi.2021.03.005', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 The Authors. Published by Elsevier Ltd on behalf of European Society of ' 'Clinical Microbiology and Infectious Diseases.', 'name': 'copyright', 'label': 'Copyright'}]}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit